Ansell Limited (ASX:ANN)
Australia · Delayed Price · Currency is AUD | Market Cap | 4.19B -15.8% |
| Revenue (ttm) | 3.01B +8.4% |
| Net Income | 202.99M +20.8% |
| EPS | 1.39 +15.5% |
| Shares Out | 140.45M |
| PE Ratio | 21.40 |
| Forward PE | 14.25 |
| Dividend | 0.79 (2.65%) |
| Ex-Dividend Date | Feb 23, 2026 |
| Volume | 316,135 |
| Average Volume | 440,223 |
| Open | 29.80 |
| Previous Close | 29.59 |
| Day's Range | 29.28 - 29.89 |
| 52-Week Range | 27.31 - 37.54 |
| Beta | 0.61 |
| RSI | 52.04 |
| Earnings Date | Aug 25, 2026 |
About Ansell
Ansell Limited designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America. It operates through two segments: Healthcare and Industrial. The Healthcare segment manufactures and markets solutions, including surgical gloves, single-use and examination gloves, and clean and sterile gloves and garments, as well as consumables for hospitals, surgical centers, dental surgeries, veterinary clinics, first respond... [Read more]
Financial Performance
In fiscal year 2025, Ansell's revenue was $2.00 billion, an increase of 23.71% compared to the previous year's $1.62 billion. Earnings were $101.60 million, an increase of 32.81%.
Financial numbers in USD Financial StatementsNews
PPE Manufacturer Ansell Still Trading at a Nice Valuation
Imagine investing in a company that made rubber gloves, facemasks and Hazmat suits during the Covid-19 pandemic. It exists!